Left atrial appendage occlusion optimized with artificial intelligence-guided CT pre-planning and intra-procedural intracardiac echocardiographic guidance.

IF 1.6 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
Sant Kumar, Mustafa Suppah, Osama Niazi, Ashish Pershad
{"title":"Left atrial appendage occlusion optimized with artificial intelligence-guided CT pre-planning and intra-procedural intracardiac echocardiographic guidance.","authors":"Sant Kumar, Mustafa Suppah, Osama Niazi, Ashish Pershad","doi":"10.1016/j.carrev.2025.03.021","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Left atrial appendage occlusion (LAAO) offers a safe alternative to oral anticoagulants for stroke prevention in patients with atrial fibrillation. This study compares the integration of preprocedural cardiac computed tomography (CT), artificial intelligence (AI) modeling, and intracardiac echocardiography (ICE) to standard transesophageal echocardiography (TEE)-guided LAAO.</p><p><strong>Methods: </strong>This single-center retrospective cohort study from 2021 to 2024 compared TEE-guided LAAO to a method combining artificial intelligence-augmented CT preplanning and ICE. The primary outcome of the study was a composite of procedural success, incidence of device-related thrombus, and peri-device leaks ≥5 mm at 45 days. Secondary outcomes included procedural duration, contrast volume, device recaptures, and resizing.</p><p><strong>Results: </strong>The study included 143 patients: 46 in the CT/ICE arm and 97 in the TEE arm. Baseline characteristics were similar in the two groups. The number of males was statistically higher in the CT/ICE arm (76.1 % vs. 58.8 % p = 0.043). Procedural success was similar between groups (97.8 % vs. 95.9 %, p = 0.899). At 45 days, device-related thrombus (2.2 % vs. 0 %, p = 0.145) and peri-device leaks were similar (8.7 % vs. 4.1 %, p = 0.266) in both groups. The CT/ICE group had significantly fewer device recaptures (0.0 ± 0.1 vs. 0.2 ± 0.4, p = 0.001) and devices attempted (1.0 ± 0.2 vs. 1.2 ± 0.4, p = 0.002).</p><p><strong>Conclusion: </strong>AI-augmented preprocedural cardiac CT planning combined with ICE has similar efficacy to TEE-guided LAAO. Due to the need for significantly fewer LAA devices and recaptures of these devices, there is the potential that AI augmented CT planning combined with ICE can reduce adverse events. The use of ICE and eliminating the need for general anesthesia and preprocedural TEE planning has the potential to improve procedural efficiency.</p>","PeriodicalId":47657,"journal":{"name":"Cardiovascular Revascularization Medicine","volume":" ","pages":""},"PeriodicalIF":1.6000,"publicationDate":"2025-03-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiovascular Revascularization Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.carrev.2025.03.021","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Left atrial appendage occlusion (LAAO) offers a safe alternative to oral anticoagulants for stroke prevention in patients with atrial fibrillation. This study compares the integration of preprocedural cardiac computed tomography (CT), artificial intelligence (AI) modeling, and intracardiac echocardiography (ICE) to standard transesophageal echocardiography (TEE)-guided LAAO.

Methods: This single-center retrospective cohort study from 2021 to 2024 compared TEE-guided LAAO to a method combining artificial intelligence-augmented CT preplanning and ICE. The primary outcome of the study was a composite of procedural success, incidence of device-related thrombus, and peri-device leaks ≥5 mm at 45 days. Secondary outcomes included procedural duration, contrast volume, device recaptures, and resizing.

Results: The study included 143 patients: 46 in the CT/ICE arm and 97 in the TEE arm. Baseline characteristics were similar in the two groups. The number of males was statistically higher in the CT/ICE arm (76.1 % vs. 58.8 % p = 0.043). Procedural success was similar between groups (97.8 % vs. 95.9 %, p = 0.899). At 45 days, device-related thrombus (2.2 % vs. 0 %, p = 0.145) and peri-device leaks were similar (8.7 % vs. 4.1 %, p = 0.266) in both groups. The CT/ICE group had significantly fewer device recaptures (0.0 ± 0.1 vs. 0.2 ± 0.4, p = 0.001) and devices attempted (1.0 ± 0.2 vs. 1.2 ± 0.4, p = 0.002).

Conclusion: AI-augmented preprocedural cardiac CT planning combined with ICE has similar efficacy to TEE-guided LAAO. Due to the need for significantly fewer LAA devices and recaptures of these devices, there is the potential that AI augmented CT planning combined with ICE can reduce adverse events. The use of ICE and eliminating the need for general anesthesia and preprocedural TEE planning has the potential to improve procedural efficiency.

通过人工智能引导的 CT 预规划和术中心内膜超声心动图引导优化左房阑尾闭塞术。
背景:左心房阑尾封堵术(LAAO)为心房颤动患者预防中风提供了口服抗凝药的安全替代方案。本研究将术前心脏计算机断层扫描(CT)、人工智能(AI)建模和心内超声心动图(ICE)整合到标准经食道超声心动图(TEE)引导的 LAAO 中进行了比较:这项 2021 年至 2024 年的单中心回顾性队列研究比较了 TEE 引导的 LAAO 与人工智能增强 CT 预规划和 ICE 结合的方法。该研究的主要结果是手术成功率、装置相关血栓发生率和45天时装置周围渗漏≥5毫米的综合结果。次要结果包括手术持续时间、造影剂用量、装置再捕获和大小调整:研究包括 143 名患者:结果:该研究共纳入 143 名患者:CT/ICE 组 46 人,TEE 组 97 人。两组患者的基线特征相似。从统计学角度看,CT/ICE 组的男性人数较多(76.1% 对 58.8% p = 0.043)。两组的手术成功率相似(97.8% 对 95.9%,P = 0.899)。45 天后,两组的器械相关血栓(2.2% 对 0%,p = 0.145)和器械周围渗漏(8.7% 对 4.1%,p = 0.266)情况相似。CT/ICE组的器械再捕获率(0.0 ± 0.1 vs. 0.2 ± 0.4,p = 0.001)和器械尝试率(1.0 ± 0.2 vs. 1.2 ± 0.4,p = 0.002)明显低于CT/ICE组:结论:人工智能增强的术前心脏 CT 规划结合 ICE 与 TEE 引导的 LAAO 具有相似的疗效。由于需要使用的 LAA 装置和这些装置的再捕获次数明显减少,人工智能增强 CT 规划结合 ICE 有可能减少不良事件的发生。使用 ICE 并省去全身麻醉和术前 TEE 计划有可能提高手术效率。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cardiovascular Revascularization Medicine
Cardiovascular Revascularization Medicine CARDIAC & CARDIOVASCULAR SYSTEMS-
CiteScore
3.30
自引率
5.90%
发文量
687
审稿时长
36 days
期刊介绍: Cardiovascular Revascularization Medicine (CRM) is an international and multidisciplinary journal that publishes original laboratory and clinical investigations related to revascularization therapies in cardiovascular medicine. Cardiovascular Revascularization Medicine publishes articles related to preclinical work and molecular interventions, including angiogenesis, cell therapy, pharmacological interventions, restenosis management, and prevention, including experiments conducted in human subjects, in laboratory animals, and in vitro. Specific areas of interest include percutaneous angioplasty in coronary and peripheral arteries, intervention in structural heart disease, cardiovascular surgery, etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信